eGenesis
Dr. Iannone is Director of Venture Investments of Leaps by Bayer, where he is responsible for developing investment cases and deal execution. As an investor, Lucio also serves as board member for Immunitas Therapeutics, Pyxis Oncology, Khloris Biosciences and Axxam. Before joining Bayer, Lucio had several senior roles in biotechnology companies and venture capital firms. He began his career at Imperial College London in the Department of Experimental Medicine where he received his Ph.D.
This person is not in the org chart
This person is not in any offices
eGenesis
2 followers
eGenesis is revolutionizing the field of transplantation with an unparalleled, multiplexed gene editing platform for the development of human-compatible organs, tissues and cells.